Acute and Substantial Vision Loss After Pembrolizumab Immunotherapy for Bladder Cancer
Year: 2025
Type: article
Study design: Case Report
Source: JAMA Ophthalmology
Language: English
Topic: Drug-Induced Ocular Toxicity
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417245922
